Your browser doesn't support javascript.
loading
Delineating the Spread and Prevalence of SARS-CoV-2 Omicron Sublineages (BA.1-BA.5) and Deltacron Using Wastewater in the Western Cape, South Africa.
Johnson, Rabia; Mangwana, Noluxabiso; Sharma, Jyoti R; Muller, Christo J F; Malemela, Kholofelo; Mashau, Funanani; Dias, Stephanie; Ramharack, Pritika; Kinnear, Craig; Glanzmann, Brigitte; Viraragavan, Amsha; Louw, Johan; Surujlal-Naicker, Swastika; Nkambule, Sizwe; Webster, Candice; Mdhluli, Mongezi; Gray, Glenda; Mathee, Angela; Preiser, Wolfgang; Vorster, Alvera; Dalvie, Shareefa; Street, Renee.
Afiliación
  • Johnson R; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, South Africa.
  • Mangwana N; Division of Medical Physiology, Faculty of Medicine and Health Sciences, Centre for Cardio-metabolic Research in Africa, Stellenbosch University, Tygerberg, South Africa.
  • Sharma JR; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, South Africa.
  • Muller CJF; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, South Africa.
  • Malemela K; Division of Medical Physiology, Faculty of Medicine and Health Sciences, Centre for Cardio-metabolic Research in Africa, Stellenbosch University, Tygerberg, South Africa.
  • Mashau F; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, South Africa.
  • Dias S; Division of Medical Physiology, Faculty of Medicine and Health Sciences, Centre for Cardio-metabolic Research in Africa, Stellenbosch University, Tygerberg, South Africa.
  • Ramharack P; Department of Biochemistry and Microbiology, University of Zululand, Kwa-Dlangezwa, South Africa.
  • Kinnear C; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, South Africa.
  • Glanzmann B; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, South Africa.
  • Viraragavan A; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, South Africa.
  • Louw J; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, South Africa.
  • Surujlal-Naicker S; Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Nkambule S; Genomics Centre, South African Medical Research Council, Tygerberg, South Africa.
  • Webster C; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.
  • Mdhluli M; Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Gray G; Genomics Centre, South African Medical Research Council, Tygerberg, South Africa.
  • Mathee A; Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, South Africa.
  • Preiser W; Department of Biochemistry and Microbiology, University of Zululand, Kwa-Dlangezwa, South Africa.
  • Vorster A; Scientific Services, Water, and Sanitation Department, City of Cape Town Metropolitan Municipality, Cape Town, South Africa.
  • Dalvie S; Environment and Health Research Unit, South African Medical Research Council, Durban, South Africa.
  • Street R; Environment and Health Research Unit, South African Medical Research Council, Johannesburg, South Africa.
J Infect Dis ; 226(8): 1418-1427, 2022 10 17.
Article en En | MEDLINE | ID: mdl-36017801

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: J Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Sudáfrica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: J Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Sudáfrica